StockData
Immunome Inc. logo

Immunome Inc. (IMNM) stock

IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$17.18−0.43 (-2.44%)

Close on Nov 17, 2026Market cap $1.95BP/E –Yield –

Immunome total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Immunome's total debt was $500.00K at Mar 31, 2021. For fiscal 2020 it was $500.00K.

Annual total debt

PeriodPeriod endValueChange
FY2020Dec 31, 2020$500.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2021Mar 31, 2021$500.00K–
Q4 FY2020Dec 31, 2020$500.00K–
Q3 FY2020Sep 30, 2020$500.00K–

More Immunome figures

See a number that looks wrong?